These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28232581)

  • 1. Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.
    Lü W; Du J; Goehring A; Gouaux E
    Science; 2017 Mar; 355(6331):. PubMed ID: 28232581
    [No Abstract]   [Full Text] [Related]  

  • 2. Opportunities for Precision Treatment of
    Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ
    J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
    Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
    Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of ligand gating and opening of NMDA receptor.
    Chou TH; Epstein M; Fritzemeier RG; Akins NS; Paladugu S; Ullman EZ; Liotta DC; Traynelis SF; Furukawa H
    Nature; 2024 Aug; 632(8023):209-217. PubMed ID: 39085540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

  • 7. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
    Karakas E; Simorowski N; Furukawa H
    Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
    Hansen KB; Ogden KK; Yuan H; Traynelis SF
    Neuron; 2014 Mar; 81(5):1084-1096. PubMed ID: 24607230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
    Yi F; Bhattacharya S; Thompson CM; Traynelis SF; Hansen KB
    J Physiol; 2019 Nov; 597(22):5495-5514. PubMed ID: 31541561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of NMDA Receptor Inhibition and Activation.
    Zhu S; Stein RA; Yoshioka C; Lee CH; Goehring A; Mchaourab HS; Gouaux E
    Cell; 2016 Apr; 165(3):704-14. PubMed ID: 27062927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mg2+ block properties of triheteromeric GluN1-GluN2B-GluN2D NMDA receptors on neonatal rat substantia nigra pars compacta dopaminergic neurones.
    Huang Z; Gibb AJ
    J Physiol; 2014 May; 592(10):2059-78. PubMed ID: 24614743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
    Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors.
    Wang H; Lv S; Stroebel D; Zhang J; Pan Y; Huang X; Zhang X; Paoletti P; Zhu S
    Neuron; 2021 Aug; 109(15):2443-2456.e5. PubMed ID: 34186027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Cell-Surface Expression of Triheteromeric NMDA Receptors.
    Yi F; Traynelis SF; Hansen KB
    Methods Mol Biol; 2017; 1677():145-162. PubMed ID: 28986871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis of the Proton Sensitivity of Human GluN1-GluN2A NMDA Receptors.
    Zhang JB; Chang S; Xu P; Miao M; Wu H; Zhang Y; Zhang T; Wang H; Zhang J; Xie C; Song N; Luo C; Zhang X; Zhu S
    Cell Rep; 2018 Dec; 25(13):3582-3590.e4. PubMed ID: 30590034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of NMDA receptors and the mechanism of inhibition by ifenprodil.
    Tajima N; Karakas E; Grant T; Simorowski N; Diaz-Avalos R; Grigorieff N; Furukawa H
    Nature; 2016 Jun; 534(7605):63-8. PubMed ID: 27135925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
    Yi F; Rouzbeh N; Hansen KB; Xu Y; Fanger CM; Gordon E; Paschetto K; Menniti FS; Volkmann RA
    Neuropharmacology; 2020 Aug; 173():107971. PubMed ID: 31987864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Cell-Surface Expression of Triheteromeric NMDA Receptors.
    Yi F; Traynelis SF; Hansen KB
    Methods Mol Biol; 2024; 2799():55-77. PubMed ID: 38727903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
    Chen X; Keramidas A; Harvey RJ; Lynch JW
    Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.